US ITC bars imports of low-cost Botox amid trade secrets dispute

18-12-2020

US ITC bars imports of low-cost Botox amid trade secrets dispute

The US International Trade Commission (ITC) has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets. 


Evolus, Allergan, AbbVie, low-cost imports, trade secrets, Botox, Medytox, Daewoong, Jeuveau

LSIPR